Compare
NAVs as of 20 Aug 2026
Edelweiss CRISIL IBX AAA Financial Services Bond - Jan 2028 Index FundDirectICICI Prudential NASDAQ 100 Index FundDirectMotilal Oswal S&P 500 Index FundDirectUTI Nifty 500 Value 50 Index FundDirect4 of 4 funds
Comparing the maximum of 4. Replace which fund?
Growth of ₹100 (rebased over the selected window)
Common period 29 Nov 2024 – 20 Aug 2026, limited by Edelweiss CRISIL IBX AAA Financial Services Bond - Jan 2028 Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Edelweiss CRISIL IBX AAA Financial Services Bond - Jan 2028 Index Fund | ICICI Prudential NASDAQ 100 Index Fund | Motilal Oswal S&P 500 Index Fund | UTI Nifty 500 Value 50 Index Fund | Nasdaq 100 | S&P 500 | Nifty 500 |
|---|---|---|---|---|---|---|---|
| 29 Nov 2024 | ₹100.00 | ₹100.00 | ₹100.00 | ₹100.00 | ₹100.00 | ₹100.00 | ₹100.00 |
| 20 Jan 2025 | ₹100.93 | ₹105.22 | ₹101.77 | ₹94.13 | ₹102.44 | ₹99.41 | ₹96.13 |
| 14 Mar 2025 | ₹102.04 | ₹94.92 | ₹94.36 | ₹88.21 | ₹94.14 | ₹93.48 | ₹88.93 |
| 05 May 2025 | ₹104.47 | ₹95.32 | ₹93.46 | ₹95.75 | ₹95.40 | ₹93.67 | ₹97.83 |
| 27 Jun 2025 | ₹105.72 | ₹109.29 | ₹103.56 | ₹100.79 | ₹107.66 | ₹102.33 | ₹104.11 |
| 18 Aug 2025 | ₹106.80 | ₹117.31 | ₹110.62 | ₹98.44 | ₹113.30 | ₹106.91 | ₹101.08 |
| 10 Oct 2025 | ₹107.99 | ₹121.58 | ₹114.21 | ₹103.77 | ₹115.73 | ₹108.62 | ₹102.87 |
| 01 Dec 2025 | ₹109.03 | ₹128.70 | ₹119.84 | ₹106.41 | ₹121.08 | ₹112.93 | ₹105.45 |
| 22 Jan 2026 | ₹109.39 | ₹132.21 | ₹124.47 | ₹110.57 | ₹121.92 | ₹114.60 | ₹101.42 |
| 16 Mar 2026 | ₹110.23 | ₹128.94 | ₹121.64 | ₹109.80 | ₹117.80 | ₹111.06 | ₹94.76 |
| 07 May 2026 | ₹111.19 | ₹153.13 | ₹135.98 | ₹119.44 | ₹136.47 | ₹121.63 | ₹102.32 |
| 29 Jun 2026 | ₹112.45 | ₹158.96 | ₹138.45 | ₹114.50 | ₹142.26 | ₹123.34 | ₹101.38 |
| 20 Aug 2026 | ₹113.45 | ₹157.97 | ₹143.95 | ₹113.63 | ₹139.67 | ₹127.34 | ₹103.64 |
| Metric | Edelweiss · Direct NAV ₹11.35 Moderate risk ★★★★★ 1Y | ICICI Prudential · Direct NAV ₹24.30 Very High risk ★★★★☆ | Motilal Oswal · Direct NAV ₹33.75 Very High risk ★★★★☆ | UTI · Direct NAV ₹22.19 Very High risk ★★★★☆ | Category median Index Funds · 375 funds |
|---|---|---|---|---|---|
| +6.21% | +37.86%Best in row | +31.67% | +14.41% | +5.66% | |
| — | +31.72%Best in row | +26.53% | +25.30% | +8.82% | |
| — | — | +17.87% | — | +9.15% | |
| +7.61% | +19.99% | +21.56% | +27.94%Best in row | +7.67% | |
| +6.83% | +29.23%Best in row | +23.81% | +15.66% | — | |
| — | +26.37% | +17.89% | +28.43%Best in row | +12.67% | |
| — | — | +17.93% | — | +13.64% | |
| Risk | |||||
| 0.94%Best in row | 21.35% | 15.43% | 20.81% | 13.97% | |
| -0.31 | 1.18 | 1.30Best in row | 0.90 | 0.24 | |
| -0.47 | 1.75 | 1.92Best in row | 1.20 | 0.36 | |
| -0.48%Best in row | -30.04% | -19.91% | -22.63% | -16.12% | |
| — | Nasdaq 100 | S&P 500 | Nifty 500 | — | |
| — | +5.10% | +4.83% | +11.51%Best in row | +0.84% | |
| — | 0.99 | 1.02 | 1.14 | 1.00 | |
| — | 109.7% | 114.0% | 139.8%Best in row | 102.2% | |
| — | 89.3% | 89.5% | 90.5% | 97.2% | |
| 0.16%Best in row | 0.63% | 0.62% | 0.80% | 0.36% | |
| ₹107.07Cr | ₹3,348Cr | ₹4,500Cr | ₹729.68Cr | ₹177.09Cr | |
| Up to 0.10% | None | 1.00% | None | — | |
| ₹100 | ₹100 | ₹500 | ₹500 | — | |
| ₹100 | ₹1.00K | ₹500 | ₹1.00K | — | |
| — | 16% | 1% | 44% | 35% | |
| Rahul Dedhia | Sharmila D'silva | Rakesh Shetty | Sharwan Kumar Goyal | — | |
| 29 Nov 2024 | 19 Oct 2021 | 29 Apr 2020 | 12 May 2023 | — | |
| — | — | — | 50 | — | |
| — | — | — | 48.8% | — | |
| 4.3% | 0.1% | 0.5% | 0.1% | — | |
3 rows carry the same value for every fund — show
- 10Y return (CAGR)
- —
- 10Y rolling avg
- —
- Lock-in
- None
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.